Close

FDA Approves Titan Pharma's (TTNP) Buprenorphine Implant for Treatment of Opioid Dependence

May 26, 2016 3:06 PM EDT Send to a Friend
The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login